Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.

Source: [Inc.](https://www.inc.com/sage-swaby/this-new-drug-could-solve-the-glp-1-plateau-problem/91411662)

Sponsored